Z56-L23
Z56-L23 is Drug-Linker Conjugates for ADC, which is composed of a linker and a Ras inhibitor (HY-178838) . Z56-L23 can be used for the research of cancer, such as pancreatic cancer[1].
Product Specifications
UNSPSC
12352005
Target
Drug-Linker Conjugates for ADC; Ras
Related Pathways
Antibody-drug Conjugate/ADC Related; GPCR/G Protein; MAPK/ERK Pathway
Field of Research
Cancer
Smiles
O=C([C@H](CCCCNC(CCOCCOCCOCCOCCOCCOCCOCCOC)=O)NC(CCN1C(C=CC1=O)=O)=O)NCCC(N[C@@H](C(C)C)C(N[C@@H](C)C(NC2=CC=C(C[N+]3(CC#CC4=C[C@]([C@]5=C(CC(C)(COC([C@H]6NN7CCC6)=O)C)C8=C(C=CC(C9=CSC(C[C@@H](C7=O)NC([C@H]%10[C@H]%11[C@@H]%10COC%11)=O)=N9)=C8)N5CC)=C([C@@H](OC)C)N=C4)CCC(C#N)CC3)C=C2)=O)=O)=O
Molecular Formula
C98H136N15O22S+
Molecular Weight
1908.28
References & Citations
[1]Zhao Jichen, et al. Macrocyclic compound and antibody-drug conjugate thereof. WO2025051241A1. 2020-03-13
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-178836/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[3077488-78-6]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items